 |
PDBsum entry 6svk
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Crystal structure and receptor-Interacting residues of mydgf - A protein mediating ischemic tissue repair.
|
 |
|
Authors
|
 |
R.Ebenhoch,
A.Akhdar,
M.R.Reboll,
M.Korf-Klingebiel,
P.Gupta,
J.Armstrong,
Y.Huang,
L.Frego,
I.Rybina,
J.Miglietta,
A.Pekcec,
K.C.Wollert,
H.Nar.
|
 |
|
Ref.
|
 |
Nat Commun, 2019,
10,
5379.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
Note: In the PDB file this reference is
annotated as "TO BE PUBLISHED". The citation details given above have
been manually determined.
|
 |
 |
|
Abstract
|
 |
|
Myeloid-derived growth factor (MYDGF) is a paracrine-acting protein that is
produced by bone marrow-derived monocytes and macrophages to protect and repair
the heart after myocardial infarction (MI). This effect can be used for the
development of protein-based therapies for ischemic tissue repair, also beyond
the sole application in heart tissue. Here, we report the X-ray structure of
MYDGF and identify its functionally relevant receptor binding epitope. MYDGF
consists of a 10-stranded β-sandwich with a folding topology showing no
similarities to other cytokines or growth factors. By characterizing the epitope
of a neutralizing antibody and utilizing functional assays to study the
activity of surface patch-mutations, we were able to localize the receptor
interaction interface to a region around two surface tyrosine residues 71 and 73
and an adjacent prominent loop structure of residues 97-101. These findings
enable structure-guided protein engineering to develop modified MYDGF variants
with potentially improved properties for clinical use.
|
 |
|
|
|
|
 |